; or (ii) individuals receiving telehealth services through federally qualified health centers (as defined in section 1861(aa)(4) of the Social Security Act ( 42 U.S.C. 1395x(aa)(4) ) or rural health clinics (as defined in section 1861(aa)(2) of such Act ( 42 U.S.C. 1395x(aa)(2) )) serving as originating sites or distant sites, and any challenges for providers furnishing telehealth services in these communities; (B) health care quality for individuals confirmed or suspected to have COVID–19 and individuals seeking care unrelated to COVID–19 as measured by— (i) quality of care metrics, such as hospital readmission rates, missed appointment rates, or wellness visits, and (ii) engagement metrics, such as voluntary patient satisfaction surveys and voluntary provider satisfaction surveys; (C) audio-only telehealth utilization rates when other video-based telehealth was not an option or any other telehealth services that were not provided in real-time (including text-messaging or through online chat platforms), the types of visits, and the types of providers treating individuals; (D) telehealth utilization rates used to treat individuals across State lines; (E) the health outcomes of any individual who utilizes telehealth services to treat an underlying health condition such as diabetes, end-stage renal disease, chronic lung disease, obstructive pulmonary disease, coronary artery disease, or cirrhosis and the types of technology utilized to receive care, including text-messaging, online chat platforms, audio-only, or video conferencing; (F) the health outcomes of any individual who utilizes mental health care and substance use disorder treatment services, and the types of technology utilized to receive care, including text-messaging, online chat platforms, audio-only, or video conferencing; (G) the impact of State and Federal privacy and security protections on the delivery of care and patient safety, including the security of the various technologies utilized to deliver or receive telehealth care